Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05353127
Other study ID # 2022_053
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 12, 2022
Est. completion date October 1, 2022

Study information

Verified date April 2022
Source VieCuri Medical Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. It is uncertain to what extent differences in data averaging methods influence the numerical value of preoperative CPET-derived variables used for risk assessment. Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.


Description:

Surgery for colorectal cancer is associated with a high incidence of postoperative complications. Risk assessment by means of a cardiopulmonary exercise test (CPET) is an essential part of the preoperative diagnostic work-up of colorectal cancer patients. During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed. The large number of data points that are collected by the breath-by-breath sampling rate can be a burden for data visualization, as they can be noisy. Therefore, data averaging is performed to optimize graphical data display and to aid CPET interpretation. To date, there are no studies quantifying the extent to which differences in data averaging influence the numerical value of preoperative CPET-derived variables for risk assessment based on aerobic fitness, such as the the oxygen uptake (VO2) at the ventilatory anaerobic threshold (VAT), VO2 at peak exercise (VO2peak), and the oxygen uptake efficiency slope (OUES), and of preoperative CPET-derived variables for risk assessment based on ventilatory efficiency, such as the ventilatory equivalent for carbon dioxide production at the VAT (VE/VCO2VAT) and the slope of the relationship between the minute ventilation and carbon dioxide production (VE/VCO2-slope). Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on the classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds. Participants Data from patients considered for colorectal cancer surgery who are ≥18 years of age, have a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire, and therefore performed preoperative CPET as a part of a prehabilitation study will be collected. Preoperative CPET was conducted before any intervention was initiated. Procedures Preoperative CPET data will be anonymized and patient characteristics other than anthropometric measures will be concealed. A medical physiologist and a clinical exercise physiologist will determine the CPET variables VO2VAT, VO2peak, respiratory exchange ratio at peak exercise (RERpeak), VE/VCO2VAT, VE/VCO2-slope, and the OUES in all 20 CPETs using a predefined set of guidelines Final determination of each parameter will be based on consensus between the two observers. In case of disagreement between observers, a third observer will be consulted. Determination of the aforementioned CPET variables will be repeated using each of the five different data-averaging intervals. Data averaging-intervals consists of a stationary time-based average over 10, 20, and 30 seconds, and of a rolling average over 3 and 7 breaths that were defined as follows. The stationary time-based average will be calculated by averaging the breath-by-breath data over 10, 20, or 30 seconds. A rolling average is defined as averaging a fixed number of single breath measurements (i.e., 3 and 7), then discarding the first breath and adding a new breath to obtain a new breath averaging block. CPET interpretation will be performed using Blue Cherry software version 1.3.3.3 (Geratherm Respiratory GmbH, Bad Kissingen, Germany). Apart from the CPET data, the preoperative patient characteristics age, sex, body mass index, smoking status (never, former, current), age-adjusted Charlson comorbidity index, comorbidities, American Society of Anesthesiologists classification, veterans-specific activity questionnaire score, hemoglobin levels (mmol/L), and tumor location will be recorded. To assess the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables, mean differences of the numerical values of VO2VAT, VO2peak, RERpeak, VE/VCO2VAT, VE/VCO2-slope, and OUES between different data-averaging intervals will be analyzed by means of within factors repeated measures analysis of variance (ANOVA). In case of a statistically significant difference between methods (p<0.05), post-hoc testing will be performed using the Bonferroni test to identify the exact differences. To evaluate the influence of data-averaging intervals on risk assessment, participants will be classified as being at low or high risk for postoperative complications based on their VO2VAT, VO2peak, VE/VCO2VAT, and OUES. For each CPET-derived variable, numerical values will be determined for each of the five data-averaging will be compared with known preoperative risk assessment thresholds (patients will be classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9, and/or an OUES/kg <20.6). Friedman's test will be used to determine whether differences in risk assessment exist between data-averaging methods. Differences between data-averaging methods will be assumed statistically significant when p<0.05.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date October 1, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patiënts with colorectal cancer, considered for surgery. - A score of =7 metabolic equivalents of task on the veterans-specific activity questionnaire and therefore performed preoperative CPET as a part of a prehabilitation study Exclusion Criteria: - Patiënt unable to perform CPET.

Study Design


Intervention

Diagnostic Test:
CPET/Cardiopulmonary Exercise Test
During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed.

Locations

Country Name City State
Netherlands Viecuri Medical Center Venlo Limburg

Sponsors (1)

Lead Sponsor Collaborator
VieCuri Medical Centre

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables. To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2VAT, Baseline, pre surgery
Primary Influence of different CPET data averaging intervals on the numerical values of CPET- To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2peak. Baseline, pre surgery
Primary Influence of different CPET data averaging intervals on the numerical values of CPET- To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2-slope. Baseline, pre surgery
Primary Influence of different CPET data averaging intervals on the numerical values of CPET- To assess the influence of different CPET data averaging intervals on the numerical the numerical values of RERpeak. Baseline, pre surgery
Primary Influence of different CPET data averaging intervals on the numerical values of CPET- To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2VAT. Baseline, pre surgery
Primary Influence of different CPET data averaging intervals on the numerical values of CPET- To assess the influence of different CPET data averaging intervals on the numerical the numerical values of the OUES. Baseline, pre surgery
Secondary High- or Low-risk for postoperative complications Patients are classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9 [12], and/or an OUES/kg <20.6 Baseline, pre surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A